Bayer Expands Research in Cancer Immunotherapy with Compugen Pact
By Heather Cartwright
Pharma Deals Review: Vol 2013 Issue 8 (Table of Contents)
Published: 12 Aug-2013
DOI: 10.3833/pdr.v2013.i8.1972 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Bayer has furthered its research focus on cancer immunotherapy by forming a collaboration with Israeli biotech Compugen, which specialises in computational approaches for drug discovery...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS